Skip to main content
Clinical Trials/IRCT20181104041551N4
IRCT20181104041551N4RecruitingPhase 3

Evaluation of the effect of melatonin on inflammatory factors and clinical outcomes in sepsis patients hospitalized in the Intensive Care Unit

Mazandaran University of Medical Sciences0 sites56 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
56

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Patients with early phase of sepsis
  • Not taking antioxidant supplements
  • Informed consent of the patient or his/her legal guardian to participate in the study

Exclusion Criteria

  • Autoimmune diseases or cancer
  • Septic shock that requires inotrope or vasopressor drugs
  • Hepatic failure
  • Renal failure requiring dialysis
  • Intestinal obstruction, ileus, gastroparesis, or other gastrointestinal conditions that can affect intestinal absorption
  • Pregnancy and breastfeeding
  • History of sleep disorders
  • Attending another study at the same time

Investigators

Similar Trials